291 related articles for article (PubMed ID: 30860438)
21. Immune checkpoint inhibitors in non-small cell lung cancer: A bird's eye view.
Memon H; Patel BM
Life Sci; 2019 Sep; 233():116713. PubMed ID: 31386875
[TBL] [Abstract][Full Text] [Related]
22. The estrogen pathway as a modulator of response to immunotherapy.
Velez MA; Burns TF; Stabile LP
Immunotherapy; 2019 Sep; 11(13):1161-1176. PubMed ID: 31361169
[TBL] [Abstract][Full Text] [Related]
23. Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapy.
Cushman TR; Caetano MS; Welsh JW; Verma V
Immunotherapy; 2018 Aug; 10(10):851-0. PubMed ID: 30073899
[TBL] [Abstract][Full Text] [Related]
24. NCCN Guidelines Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung Cancer.
Gubens MA; Davies M
J Natl Compr Canc Netw; 2019 May; 17(5.5):574-578. PubMed ID: 31117034
[TBL] [Abstract][Full Text] [Related]
25. Immune checkpoint therapy for non-small-cell lung cancer: an update.
Xia B; Herbst RS
Immunotherapy; 2016; 8(3):279-98. PubMed ID: 26860624
[TBL] [Abstract][Full Text] [Related]
26. Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer.
Lim SW; Ahn MJ
Korean J Intern Med; 2019 Jan; 34(1):50-59. PubMed ID: 30612418
[TBL] [Abstract][Full Text] [Related]
27. A banner year for immunotherapy and targeted therapy.
Carlisle JW; Ramalingam SS
Nat Rev Clin Oncol; 2019 Feb; 16(2):79-80. PubMed ID: 30538305
[No Abstract] [Full Text] [Related]
28. Prognostic Factors and Biomarkers of Responses to Immune Checkpoint Inhibitors in Lung Cancer.
Bianco A; Perrotta F; Barra G; Malapelle U; Rocco D; De Palma R
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590386
[TBL] [Abstract][Full Text] [Related]
29. [Role of immunotherapy in locally advanced non-small cell lung cancer].
Levy A; Doyen J; Botticella A; Bourdais R; Achkar S; Giraud P; Du C; Naltet C; Lavaud P; Besse B; Pradère P; Mercier O; Caramella C; Planchard D; Deutsch E; Le Péchoux C
Cancer Radiother; 2020 Feb; 24(1):67-72. PubMed ID: 32037126
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy in Lung Cancer: A New Age in Cancer Treatment.
Corrales L; Scilla K; Caglevic C; Miller K; Oliveira J; Rolfo C
Adv Exp Med Biol; 2018; 995():65-95. PubMed ID: 30539506
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy and Immunotherapy Combinations for Lung Cancer.
Agrawal V; Benjamin KT; Ko EC
Curr Oncol Rep; 2020 Nov; 23(1):4. PubMed ID: 33215306
[TBL] [Abstract][Full Text] [Related]
32. Current landscape of immunotherapy for the treatment of metastatic non-small-cell lung cancer.
Pabani A; Butts CA
Curr Oncol; 2018 Jun; 25(Suppl 1):S94-S102. PubMed ID: 29910652
[TBL] [Abstract][Full Text] [Related]
33. Toxicity patterns associated with chemotherapy/immune checkpoint inhibitor combinations: a meta-analysis.
Abdel-Rahman O
Immunotherapy; 2019 Apr; 11(6):543-554. PubMed ID: 31135244
[No Abstract] [Full Text] [Related]
34. Immunotherapy in Lung Cancer: From a Minor God to the Olympus.
Russo A; McCusker MG; Scilla KA; Arensmeyer KE; Mehra R; Adamo V; Rolfo C
Adv Exp Med Biol; 2020; 1244():69-92. PubMed ID: 32301011
[TBL] [Abstract][Full Text] [Related]
35. Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back?
Di Nunno V; Gatto L; Fragomeno B; Cubelli M; Nobili E; Romano I; Santoni M; Pisconti S; Montironi R; Massari F
Future Oncol; 2018 Dec; 14(29):2997-2999. PubMed ID: 30411632
[No Abstract] [Full Text] [Related]
36. Predictive Biomarkers for Checkpoint Blockade in Urothelial Cancer: A Systematic Review.
Lavoie JM; Black PC; Eigl BJ
J Urol; 2019 Jul; 202(1):49-56. PubMed ID: 30730407
[TBL] [Abstract][Full Text] [Related]
37. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
38. [Immunotherapy in the Treatment of Lung Cancer].
Fiala O; Šorejs O; Pešek M; Fínek J
Klin Onkol; 2017; 30(Supplementum3):22-31. PubMed ID: 29239189
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy for lung cancer: for whom the bell tolls?
Madureira P; de Mello RA; de Vasconcelos A; Zhang Y
Tumour Biol; 2015 Mar; 36(3):1411-22. PubMed ID: 25736929
[TBL] [Abstract][Full Text] [Related]
40. PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?
Tanvetyanon T; Gray JE; Antonia SJ
Expert Opin Biol Ther; 2017 Mar; 17(3):305-312. PubMed ID: 28064556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]